A Phase I clinical trial has demonstrated two investigational Ebola vaccines generate a durable immune response 1 year after vaccination.
Researchers have demonstrated that Trypanosoma brucei, the parasite responsible for sleeping sickness, has its own molecular clock, which could affect the parasite’s sensitivity to treatments.
Researchers have demonstrated that MRI scans could help to diagnose patients with cognitive problems due to HIV-related inflammation, presenting an alternative to lumbar punctures.
New findings have identified the exact mechanism by which the bacterium Salmonella typhimurium can escape degradation by autophagy.
Researchers have suggested Zika may have adverse effects on the cardiovascular system based on new data from a small case report; an association which has previously been unreported.
New study in mouse models suggests immune adaptation in pregnancy reduces the antiviral response allowing the influenza virus to mutate to more virulent strains and causing more severe infections.
The first study to investigate attitudes to the child flu vaccine in the UK has reported that concerns around the vaccines safety, efficiency and side effects may be reducing uptake.
Researchers have analyzed the clinical characteristics of Zika infection in Canadian travelers returning from the Americas, discovering that severe complications might be more common than previously estimated.
Researchers from Durham University have developed a new, simplified production process for a drug vital to treating cryptococcal meningitis; they hope this will reduce the drug’s cost and increase its availability in developing countries.
Researchers have discovered a novel regulator of the innate immune response that may lead to the development of new antivirals and vaccines.